×
  • World - Europe
  • Updated: April 22, 2020

Germany To Commence Clinical Trials On COVID-19 Vaccine

Germany To Commence Clinical Trials On COVID-19 Vaccine

The first series of clinical trials of a vaccine for the coronavirus pandemic has been authorised by the German Government, this is according to the country's regulatory body, giving the go-ahead on the use of the vaccines on human subjects as developed by German firm Biontech and US giant Pfizer.

READ ALSOCOVID-19: UK To Commence Clinical Trials Of Vaccine On Patients From Thursday

The regulatory body said, “The Paul-Ehrlich-Institut… has authorised the first clinical trial of a vaccine against COVID-19 in Germany."

It also said that the approval of the test was the “result of a careful assessment of the potential risk/benefit profile of the vaccine candidate."

Related Topics

Join our Telegram platform to get news update Join Now

0 Comment(s)

See this post in...

Notice

We have selected third parties to use cookies for technical purposes as specified in the Cookie Policy. Use the “Accept All” button to consent or “Customize” button to set your cookie tracking settings